BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Topics
»
Disease categories and therapies
» Substance use and poisoning
Substance use and poisoning
RSS
Patient enrollment advances ahead of schedule in phase III Probuphine trial
Aug. 4, 2010
FDA grants CBLB-502 fast track status for acute radiation syndrome
July 23, 2010
Cangene's option to license Maxygen's MAXY-G34 for ARS expires
July 19, 2010
Nabi completes enrollment in first of two phase III NicVAX trials
July 15, 2010
Effect of citalopram on drinking depends on goals of alcohol-dependent subjects
July 13, 2010
FDA schedules review of Alkermes' Vivitrol sNDA for opioid dependence
June 21, 2010
Protalix BioTherapeutics completes phase I trial of PRX-105
June 10, 2010
FDA grants priority review to Vivitrol sNDA for opioid dependence
May 27, 2010
Cleveland BioLabs completes dosing in second safety study for CBLB-502
May 11, 2010
BARDA exercises options on Cleveland BioLabs contract to develop CBLB-502
May 3, 2010
Previous
1
2
…
55
56
57
58
59
60
61
62
63
…
119
120
Next
RSS